{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:15:53Z","timestamp":1759940153556,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.annder.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T11:44:25Z","timestamp":1536666265000},"page":"765-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cytop\u00e9nies sous imiquimod topique chez deux patients trait\u00e9s par hydroxyur\u00e9e"],"prefix":"10.1016","volume":"145","author":[{"given":"C.","family":"Joachim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Gras-Champel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Marolleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Chaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Carmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.07.012_bib0035","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ijd.13235","article-title":"Imiquimod in dermatology: an overview","volume":"55","author":"Hanna","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2018.07.012_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00403-004-0465-4","article-title":"Pharmacokinetics and safety of imiquimod 5\u00a0% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms","volume":"296","author":"Harrison","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2018.07.012_bib0045","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit: Aldara cr\u00e8me 5%. (En ligne). Disponible sur\u00a0: http:\/\/ansm.sante.fr\/Produits-de-sante\/Medicaments. [Mise \u00e0 jour le 03 septembre 2008, consult\u00e9 le 26 mai 2017]"},{"key":"10.1016\/j.annder.2018.07.012_bib0050","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bjc.1996.569","article-title":"A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily","volume":"74","author":"Savage","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annder.2018.07.012_bib0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000104264","article-title":"5\u00a0% topical imiquimod tolerance in transplant recipients","volume":"215","author":"Ben M\u2019barek","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2018.07.012_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5\u00a0% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients","volume":"157","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:36Z","timestamp":1758971196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818305039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0151963818305039"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.012","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytop\u00e9nies sous imiquimod topique chez deux patients trait\u00e9s par hydroxyur\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}